Cristal Therapeutics

Cristal Therapeutics is a clinical-stage pharmaceutical company developing targeted nanomedicines with superior therapeutic properties for the treatment of cancer and other diseases with high unmet patient needs and significant commercial potential. Our lead product candidates are centered on our proprietary polymeric nanoparticle architecture, which we refer to as CriPec®. They are rationally designed to target specific tissues, cells, and intracellular components, with a defined duration at the disease site.